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Thomas Hatsukami, MD, Mark Meissner, MD, Gale Tang, MD, and Ted Kohler, MD, Seattle, Wash
Objectives:Our institution treats about 30 patients per year with ruptured abdominal aortic aneurysms (rAAA). Between
2002 and 2007, our 30-day mortality averaged 58%. In July 2007, we implemented an algorithm to promote
endovascular aneurysm repair (EVAR) when feasible. This report describes the outcome with this approach.
Methods: Data on patients presenting with rAAA between July 1, 2002, and June 30, 2007, were reviewed and used for
comparison to prospectively collected data. Data on patients presenting between July 1, 2007, and April 30, 2009, were
collected on all patients after implementation of a structured protocol. The primary outcome measure was 30-day
mortality. Data were analyzed using logistic regression. Kaplan-Meier survival curves and a log-rank test were performed
to compare survival times for three groups (pre-protocol, post-protocol with open surgery, and post-protocol with
EVAR).
Results: During the study period, 187 patients with rAAA presented to our institution. Before implementation of the
algorithm, 131 patients with rAAA presented and 128 were treated. The 30-day mortality rate was 57.8%. After
implementation of the protocol, 56 patients with rAAA were managed. Twenty-seven patients (48%) underwent
successful EVAR, and 24 patients (43%) underwent open repair. Five patients (9%) underwent comfort care only. In the
post-protocol period, 5 patients in the EVAR group (18.5%) and 13 patients in the open group (54.2%) died during the
follow-up period for an overall 30-day mortality rate of 35.3% (P  .008 vs 57.8% pre-protocol). After implementation
of a structured protocol for managing rAAA, there was a relative risk reduction in 30-day mortality of 35% compared to
the time before implementation of the protocol (95% confidence interval [CI], 14%-51%) corresponding to an absolute
risk reduction of 22.5% (95% CI, 6.8%-38.2%) and an odds ratio of 0.40 (95% CI, 0.20-0.78; P  .007). After adjusting
for key factors predicting mortality, the odds ratio is 0.25 (95% CI, 0.10-0.57; P  .001).
Conclusion:Use of an algorithm favoring endovascular repair resulted in a highly significant reduction in rAAAmortality
in our urban hospital. Thirty-day mortality for open repair was no different between pre- and post-protocol eras. With
modern techniques of resuscitation and surgical management, a majority of patients presenting with rAAA can survive.
(J Vasc Surg 2010;51:9-18.)Harborview Medical Center is a level 1 trauma center
serving five states with a geographic area 27% of the land
mass of the United States. Just over 10 million people are
served, representing 3.4% of the U.S. population in 2007.1
Because of this unique setting, our institution treats a wide
range of aortic pathology, including between 30 and 50
patients per year with ruptured abdominal aortic aneurysm
(rAAA). In 1991, Johansen et al2 published a 10-year
experience of 186 patients with rAAA treated at Harbor-
view Medical Center.2 The overall 30-day mortality was a
somber 70%.
With the advent of elective endovascular aortic aneu-
rysm repair (EVAR), randomized controlled trials and pop-
ulation-based studies have shown a marked reduction in
30-day mortality when compared with standard open re-
pair.3-5 Since the first successful endovascular repair of an
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doi:10.1016/j.jvs.2009.08.038rAAA by Marin and Veith et al6 in 1994, few institutions
have adopted this approach in a structured fashion for the
management of this devastating disease. The use of EVAR
for rAAA has not been associated with improved outcomes
in most series, although some have suggested that a struc-
tured approach may have this result.7,8
A recent internal review of our own experience revealed
a modest but significant decrease in overall 30-day mortal-
ity over the 27-year interval comparing the period between
2002 and 2007 (59%; n  131) with the period between
1980 and 1989 (70%; n  186) P  .04. In July 2007, we
implemented an algorithm to manage these patients with a
preference for endovascular repair when feasible. The ob-
jective of the current study is to evaluate the effect of this
algorithm on mortality.
METHODS
In July of 2007, we implemented an Institutional Re-
view Board-approved protocol for managing patients with
rAAA. This was a prospective nonrandomized intent-
to-treat study with comparison to historic controls. All
patients presenting with a diagnosis of rAAA were included
in the analysis, and data were collected prospectively. Our
algorithm for managing these patients was adapted from
Mehta et al8 and is depicted in Fig 1. Briefly, patients
presenting with an rAAA are divided into one of two
9
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blood pressure [SBP]80 mmHg) or unstable (SBP80
mm Hg or with lack of neurocognitive ability). Stable
patients who arrived without having a computed tomo-
graphic angiogram (CTA) rapidly received one. Stable pa-
tients were then transferred urgently to the operating room
when the CTAwas available. Unstable patients were imme-
diately transferred to the operating room without a CTA.
Once in the operating room, the patients were initially
managed awake with a preference for local or no anesthesia
and percutaneous transfemoral placement of a prophylactic
aortic occlusion balloon (CODA balloon, COOK-Medical,
Bloomington, Ind) with sheath support as described by
Malina et al.9 The balloon was briefly inflated to profile to
determine the amount of dilute contrast required for blind
inflation and aortic occlusion if needed. Patients presenting
in hemorrhagic shock often require no anesthesia for per-
cutaneous placement of a sheath in the femoral artery. The
added time required to inject local anesthesia in these
unstable patients was deemed excessive. Balloons were only
placed in those patients thought to be unstable and in
patients undergoing open repair by a surgeon familiar with
endovascular techniques. Once an assessment was made of
the anatomic suitability for EVAR, the patient was either
electively intubated for open repair under general anesthe-
sia with the use of a protective aortic occlusion balloon as
needed or underwent rapid EVAR with a preference for
local or no anesthesia. Heparin was used selectively. Dilute
heparinized saline solution was used to flush sheaths in
patients receiving no systemic heparin. The majority of
patients underwent EVAR with a COOK Zenith modular
bifurcated endoprosthesis (COOK-Medical). Type 1 en-
doleaks were managed in the operating room. If a type 2
endoleak was identified on completion imaging, no inter-
Fig 1. Structured algorithm for managing patients with ruptured
abdominal aortic aneurysms (rAAA). SBP, Systolic blood pressure;
CTA, computed tomographic angiogram; Fr, French size; AOB,
aortic occlusion balloon; IVUS, intravascular ultrasound; GETA,
general endotracheal anesthesia; EVAR, endovascular aneurysm
repair.vention was performed at that time.A strong emphasis was made to only place bifurcated
grafts to mimic native anatomy. Unibody systems were
used only when coexistent unilateral iliac occlusion was
present or if prolonged attempts at gate cannulation were
futile. Traditional crossover femoral-femoral bypass was
conducted at the completion of any unibody construct.
An rAAA was defined by evidence of blood outside of
the aorta at any time during evaluation. Conventional
exclusion criteria for EVAR were utilized and included: (1)
aortic neck diameter of no greater than 32mm, neck length
shorter than 15 mm, significant calcification (circumferen-
tial), thrombus (40%) or greater than 60 degrees of aortic
neck angulation; and (2) iliac vessels less than 6.5 mm in
diameter for delivery of the main body graft or with signif-
icant tortuosity. Over the study period, as our experience
increased, these selection criteria became less stringent.
Included in this study were patients with juxta- and para-
renal ruptured aneurysms as well; the majority underwent
open repair.
An estimate was made based on patient presentation,
discussion with family members, and chart documentation
as to the estimated time of rupture. “Rupture time” was
defined as the time between estimated time of rupture and
arrival in the Harborview Emergency Department (ED).
Transport time was calculated as the duration between time
of arrival in the ED and time of arrival in the operating
theater.
STATISTICAL METHODS
The primary outcome measure was 30-day mortality
rate. We also examined in-hospital mortality rate. We cal-
culated and compared the proportion of subjects who died
before 30 days for the pre-protocol era (July 1, 2002 to
June 30, 2007) and the post-protocol era (July 1, 2007 to
April 30, 2009). Within the post-protocol era, we com-
pared subjects undergoing open surgery to those undergo-
ing EVAR. Proportions were compared using a 2 test. In
situations where the expected cell sizes were less than five,
we used Fisher’s exact test. In addition to examining the
30-day mortality rate, we also constructed Kaplan-Meier
survival curves and performed a log-rank test comparing
survival times for the three groups (pre-protocol, post-
protocol with open surgery, and post-protocol with
EVAR). We used logistic regression to test for a difference
in 30-day mortality in the pre- and post-protocol era, using
the pre-protocol era as the reference. We also used logistic
regression to test for univariate associations between 30-
day mortality and substrata of demographic, pre-hospital,
and presenting characteristics. We constructed a multivari-
ate logistic model to examine differences in 30-day mortal-
ity in the pre- and post-protocol eras adjusting for key
factors that were significantly associated with mortality in
the univariate analysis. We present odds ratios (ORs) and
95% confidence intervals (CIs). Note, the OR should not
be interpreted as an approximation of the relative risk
because our outcome is not rare. We were able to calculate
rupture and transport times for 147 of 179 subjects. Rup-
ture time was calculated as the duration between the esti-
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Transport time was calculated as the duration between time
of arrival at the ED and time of arrival to the operating
room. We used a t test to compare transfusion require-
ments, rupture times, and transport times. Because this
analysis was exploratory, we did not adjust for multiple
comparisons. All analysis was performed using SPSS (SPSS
Inc, Chicago, Ill) and STATA (StataCorp, College Station,
Tex).
RESULTS
Study population characteristics. During the study
period, 187 patients with rAAA presented to our institu-
tion. Demographics for the entire study population are
divided into pre- and post-protocol groups and are listed in
Table I. Before implementation of the algorithm, 131
patients with rAAA presented to our hospital, and 128 were
treated. A single patient during this time period was treated
with EVAR and survived. Sixty-five percent of these pa-
tients were hypotensive (SBP 80 mm Hg) on presenta-
tion. After implementation of the protocol, 56 patients
with rAAA were managed. Twenty-seven patients (48%)
underwent EVAR, and 24 patients (43%) underwent open
repair. Five patients (9%) underwent comfort care only. In
the post-protocol group, 37/51 (72.6%) presented with
hypotension. There was no significant difference in the
Table I. Basic demographics and pre-hospital characterist
Characteristic Pre-protocol
N 128
Male 100 (78.2%)
Age
60 7 (5.5%)
60-69 35 (27.6%)
70-79 41 (32.3%)
80-89 42 (33.1%)
90 2 (1.2%)
SBP 80 83 (64.9%)
CPR 4 (3.2%)
CT scanb 76 (65.5%)
Hematocrit 25 28 (21.9%)
Creatinine 2 47 (36.7%)
Rupture time 10 hours 28 (23.3%)
CAD 66 (56.9%)
HTN 73 (62.9%)
COPD 33 (28.4%)
Renal insufficiencyb 7 (6.03%)
Diabetes 14 (12.2%)
SBP, Systolic blood pressure.
aThis table provides the total number of subjects in each category and the per
resuscitation (CPR), 2 subjects are missing data in the pre-protocol grou
pre-protocol group and 6 in the post-protocol group (6 in the open group
pre-protocol group and 10 in the post-protocol group (4 in the open grou
(HTN), and chronic obstructive pulmonary disease (COPD) 12 subjects are
open group and 3 in the EVAR group). Note, these are not the same patients
in the pre-protocol group and 6 in the post-protocol group (3 in the open gr
bThe CT scans and renal insufficiency are statistically different between pr
between pre and post or between open and EVAR.incidence of hypotension between pre- and post-protocolgroups or between post-protocol EVAR and open groups.
CT scans were more common in later years, as was the
incidence of patients presenting with renal insufficiency.
The mean follow-up period was 164 days (range, 0-365
days). For patients who did not die in the first 30 days, the
mean follow-up period was 332 days (range, 68-365 days).
Thirty-day mortality. The 30-day mortality rate for
the pre-protocol group was 57.8% (Table II). During the
post-protocol era, 5 patients in the EVAR group (18.5%)
and 14 patients in the open group (54.2%) died for an
overall 30-day mortality rate of 35.3%. The absolute risk
difference was 22.5% (95% CI, 6.8%-38.2%). The OR com-
paring the post-protocol group to the pre-protocol group
was 0.40 (95% CI, 0.20-0.78; P  .007; Table III). After
adjustment for age, pre-hospital systolic blood pressure,
hematocrit (HCT), and the number of transfused units, the
OR was even lower (OR  0.25; 95% CI, 0.10-0.57; P 
.001; Table IV).
Kaplan-Meier survival curves of patients undergoing
EVAR or open repair in the pre- and post-protocol era are
shown in Fig 2. There was a significant difference in survival
between pre- and post-protocol groups that favored the
structured algorithm (P  .005). There was also a signifi-
cant difference between EVAR and open groups in the
post-protocol era favoring EVAR (P  .006).
We evaluated the percentage of patients treated with
Post-protocol
Total Open EVAR
51 24 27
0 (78.4%) 17 (70.8%) 23 (85.2%)
0 0 0
0 (19.6%) 4 (16.7%) 6 (22.2%)
9 (37.3%) 7 (29.2%) 12 (44.4%)
0 (39.2%) 12 (50.0%) 8 (29.6%)
2 (4.0%) 1 (4.2%) 1 (3.7%)
7 (72.6%) 19 (79.2%) 18 (66.7%)
5 (9.8%) 3 (12.5%) 2 (7.4%)
2 (93.3%) 16 (88.9%) 26 (96.3%)
2 (23.5%) 4 (16.7%) 8 (29.6%)
7 (52.9%) 15 (62.5%) 12 (44.4%)
8 (19.5%) 2 (10.0%) 6 (28.6%)
3 (51.1%) 10 (47.6%) 13 (54.2%)
4 (75.6%) 18 (85.7%) 16 (66.7%)
5 (33.3%) 8 (38.1%) 7 (29.2%)
1 (24.4%) 3 (14.3%) 8 (33.3%)
5 (11.1%) 2 (9.5%) 3 (12.5%)
e. Percentages are based on non-missing observations. For cardiopulmonary
r computed tomography (CT) scans, 12 subjects are missing data in the
in the EVAR group). For rupture time, 8 subjects are missing data in the
6 in the EVAR group). For coronary artery disease (CAD), hypertension
g data in the pre-protocol group and 6 in the post-protocol group (3 in the
re missing CT scan data. For renal insufficiency, 13 subjects are missing data
d 3 in the EVAR group). None of the other variables have any missing data.
post-protocol era. No other demographics are statistically different eithericsa
4
1
1
2
3
4
1
2
2
3
1
1
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p. Fo
and 0
p, and
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that a
oup an
e andEVAR and the resultant 30-day mortality by time periods.
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treated with EVAR by year and the 30-day mortality rate
for both open surgery and EVAR by year. There is an
overall trend for a higher percentage of patients treated
with EVAR in the second year of the study (63.2% in year 2
vs 46.3% in year 1; P  .20). Similarly, there is a trend for
improved survival of EVAR patients over time. The 30-day
survival for EVAR patients in year 2 of the study is 91.7%
(P  .14 comparing year 1 and year 2 in the EVAR group;
Fig 3).
In-hospital mortality. Two patients surviving 30
days experienced in-hospital mortality. One patient in the
pre-protocol group and 1 patient in the post-protocol
EVAR group died in the hospital after 30 days. In-hospital
mortality was 58.6% for pre-protocol, 54.2% for post-
protocol open surgery, and 22.2% for post-protocol EVAR.
For patients who did not die in the first 30 days, the mean
hospital stay in the pre-protocol era was 31.3 days (range,
Table II. Thirty-day survival
Pre-protocol Post-protocol
Total N 128 51
N died in 30 days 74 18
30-day mortality rate 57.8% 35.3%
EVAR, Endovascular aneurysm repair; N, number.
Relative risk: 35% reduction (95% CI, 14%-51%).
Absolute risk difference: 22.5% (95% CI, 6.8%-38.2%).
aP value from 2 test comparing pre- and post-protocol.
bP value from exact test comparing EVAR and open among post-protocol.
Table III. Univariate odds ratios of 30-day mortality for
different patient characteristics
Characteristic Odds ratio 95% CI P value
Time period
Pre-protocol Reference
Post-protocol 0.40 0.20-0.78 .007
Gender
Male Reference
Female 1.14 0.56-2.33 .71
Age group
70 years Reference
70-79 years 1.77 0.82-3.79 .14
80 years 3.78 1.75-8.13 .001
Pre-hospital systolic blood
pressure 80
No Reference
Yes 4.64 2.34-9.19 .001
HCT 25
No Reference
Yes 0.23 0.10-0.51 .001
Serum creatinine 1.5
No Reference
Yes 1.09 0.60-1.98 .77
Transfusion units 10
No Reference
Yes 2.31 1.21-4.39 .010
CI, Confidence interval; HCT, hematocrit.3-232), and the mean hospital stay in the post-protocol erawas 18.63 days (range, 1-67). Although the time is shorter
for the post-protocol group, this was not a statistically
significant difference (P .10). Within the post-protocol
era, the mean hospital stay for patients with open surgery
who did not die in the first 30 days was 27.4 days (range,
6-67) and 14.2 days (range, 1-57) for patients with EVAR.
The difference between the two groups was statistically
significant (P  .037).
Factors related to mortality for EVAR and
open repair
Age. Patients undergoing EVAR tend to be younger
than those who undergo open surgery (Table I - basic
demographics), although this is not statistically significant.
In both the pre- and post-protocol periods, mortality in-
creases with increasing age and is statistically different (P
.008 in the pre-protocol era and P  .016 in the post-
protocol era). In the post-protocol era, mortality is 0% for
people under 70 in both the EVAR and open groups (Fig
4). In the post-protocol era, mortality is lower with EVAR
than open repair for all ages.
Gender. A higher proportion of patients undergoing
EVAR are male (85.2%), compared to patients undergoing
P valuea Open EVAR P valueb
24 27
13 5
.008 54.2% 18.5% .010
Table IV. Odds ratios of 30-day mortality from a
multivariate model
Characteristic Odds ratio 95% CI P value
Time period
Pre-protocol Reference
Post-protocol 0.25 0.10-0.57 .001
Age group
70 years Reference
70-79 years 3.01 1.19-7.62 .020
80 years 6.53 2.50-17.01 .001
Pre-hospital systolic blood
pressure 80
No Reference
Yes 5.01 2.23-11.2 .001
HCT 25
No Reference
Yes 0.28 0.11-0.72 .008
Transfusion units 10
No Reference
Yes 2.41 1.10-5.30 .028
CI, Confidence interval; HCT, hematocrit.open surgery (70.8%); although this is not significantly
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ing EVAR (4 patients total) do not have the same reduction
in mortality as their male counterparts. The women under-
going EVAR are all older, but this does not explain the
disparity in mortality when one evaluates the overall rela-
tionship between age and mortality for the EVAR group
above.
Systolic blood pressure. For patients presenting with
SBP 80 mm Hg at any time before definitive interven-
tion, there is a significant mortality risk for both pre- and
post-protocol groups (Tables III and IV). For patients
having SBP greater than 80 mm Hg in the post-protocol
era, survival is 100%. In the pre-protocol era, 65.4% of
patients had a pre-hospital SBP 80 mm Hg and in post-
Fig 2. Kaplan-Meier survival curve up to 30 days for all three
groups; pre-protocol open (green), post-protocol open (red), and
post-protocol EVAR, Endovascular aneurysm repair (blue).
Fig 3. The 30-day mortality for both open surgery and endovas-
cular aneurysm repair (EVAR) by year in the post-protocol period.
There is a trend for improved survival of EVAR patients over time
(P  .14 comparing year 1 and 2 in the EVAR group).protocol open-treated patients, it was 79.2% (P  .24).Serum HCT and creatinine. Overall, serum HCT of
25% on presentation was associated with lower 30-day
survival compared toHCT25% (P .001; Tables III and
IV). A similar trend was observed in the pre- and post-
protocol era and in both the open surgery and EVAR arms,
but this difference was not statistically significant. In the
pre-protocol era, 21.9% of patients had anHCT25%, and
in post-protocol open-treated patients, it was 16.7%
(P .39). Within the post-protocol group, 30-day mortal-
ity for the 4 patients with HCT 25% treated with open
repair was 100%, compared to only 37.5% for the 8 patients
with HCT 25% in the EVAR group. In contrast, there
was no significant association between serum creatinine and
survival for either a cutpoint of 1.5 or 2.0 mg/dL (data not
shown).
Comorbidities. None of the comorbidities (coronary
artery disease, hypertension, chronic obstructive pulmo-
nary disease, renal insufficiency, and diabetes mellitus) were
associated with mortality in any time period or group (data
not shown).
Transfusion requirement. The transfusion require-
ment in the pre-protocol era (mean  10.6; range, 0-37)
was significantly higher than in the post-protocol era (mean
5.4; range, 0-19); P  .001. In the post-protocol era, the
EVAR group had a mean transfusion requirement of 2.11
units (range, 0-13), and the open group had a mean
requirement of 12.5 units (range, 2-19); P  .001.
Overall blood transfusion requirement was a significant
predictor of mortality. Overall, there was no association
with a cutoff of two units (OR 1.26; 95% CI, 0.69-2.32;
P .45). Therewas an association with a cutoff of five units
(OR  1.92; 95% CI, 1.06-3.47; P  .032) and with a
cutoff of 10 units (OR  2.31; 95% CI, 1.21-4.39; P 
.01). However, it is worth noting that within categories (ie,
within pre-protocol, post-protocol open, and EVAR) there
was no statistical difference in the number of transfused
units between those who survived and those who died (all
P  .4).
Rupture and transport time. There was a trend for
both rupture and transport times to be longer for patients
who died within 30 days, although there was only a statis-
tically significant association with mortality for transport
time and not rupture time in patients with open surgery. In
the pre-protocol era, the mean rupture time was 6 hours 55
minutes (range, 32 minutes-24 hours 0 minutes) for pa-
tients who survived to 30 days, and 6 hours 13 minutes
(range, 5 minutes-23 hours 50 minutes) for patients who
died within 30 days (P value comparing the two groups 
.56). In the post-protocol era for patients undergoing open
surgery, the average rupture time was 5 hours 35 minutes
(range, 2 hours 40 minutes-12 hours 0 minutes) for pa-
tients who survived to 30 days, and 3 hours 54 minutes
(range, 24 minutes-10 hours 27 minutes) for those who
died (P  .28). For patients undergoing EVAR, the aver-
age rupture time was 8 hours 33 minutes (range, 45 min-
utes-23 hours 30 minutes) for patients who survived to 30
days, and 6 hours 37 minutes (range, 3 hours 7 minutes-8
hours 45 minutes) for those who died (P  .64).
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hour to 23 minutes (range, 5 minutes-11 hours 32 min-
utes) for patients who survived to 30 days, and 52 minutes
(range, 0 minutes-4 hours 24 minutes) for patients who
died within 30 days (P value comparing the two groups 
.059). In the post-protocol era for patients undergoing
open surgery, the average transport time was 1 hour 56
minutes (range, 26 minutes-4 hours 50 minutes) for pa-
tients who survived to 30 days and 42 minutes (range, 8
minutes-3 hours 0 minutes) for those who died (P .025).
For patients undergoing EVAR, the average transport time
was 1 hour 49 minutes (range, 13 minutes-10 hours 45
minutes) for patients who survived to 30 days and 1 hour
31 minutes (range, 43 minutes-4 hours 11 minutes) for
those who died (P  .83).
Operative time. The mean operative times for EVAR
cases was 2 hours and 47 minutes (range, 1 hour 16
minutes-7 hours flat). It is important to note that operative
time was calculated from the patient’s arrival to the oper-
ating room until the patient exited from the operating
room. There was no improvement in operative times for
EVAR over the study period (2 hours, 15minutes in year 1,
3 hours and 23 minutes in year 2). There was also no
association between operative time andmortality for EVAR
patients. The mean time was 2 hours and 48 minutes for
those who survived 30 days and 2 hours, 40 minutes for
those who died within 30 days (P  .86). Prolonged
operative times for EVAR did not translate into an increase
in mortality risk.
Cardiopulmonary resuscitation. There are 9 pa-
tients listed as having cardiopulmonary resuscitation (CPR)
in the pre-hospital time period, 4 in the pre-protocol
group, 3 in the post-protocol open, and 2 in the post-
protocol EVAR groups. None of the patients in the pre-
protocol group survived, 1 of 3 in the post-protocol open
group, and 2 of 2 in the post-protocol EVAR group sur-
vived. These numbers are too small to do any meaningful
statistics, but there were indeed survivors among patients
who had CPR before going to the operating room.
Aortic occlusion balloon. Transfemoral aortic occlu-
sion balloons were placed in 21 patients over the entire
Fig 4. The 30-day mortality by age group. Mortality in
and P  .016 in the post-protocol era).study period. In the pre-protocol group, 4 patients hadballoons placed. Two of these balloons were used for aortic
occlusion and both patients died. Two were never inflated
and 1 patient survived. In the post-protocol period, 17
patients had balloons placed. Nine were actually used to
occlude the aorta; four in patients having open repair all of
whom died (100%) and five in patients undergoing EVAR
where only 1 patient died (20%). Eight balloons were
placed and not used; three in patients having open repair
where 1 patient died (33%) and five in patients undergoing
EVAR where only 1 patient died (20%). Use of balloons in
the open repair cohort was associated with a 71% mortality
rate, whereas use in the EVAR cohort was associated with a
20% mortality rate (P  .03). There were no noted com-
plications related to balloon occlusion.
Abdominal compartment syndrome. Abdominal
compartment syndrome (ACS) was documented in 32
patients over the study period. In the pre-protocol period,
24 patients had ACS (all open repairs) and 9 survived
(62.5% mortality rate). In the post-protocol period, 8 pa-
tients had ACS; six open repairs with one survivor (83%
mortality) and two EVARs with one survivor (50% mortal-
ity). One early endoleak (type 1) was initially undetected on
completion imaging, and this patient died. This endoleak
was identified on reoperation and conversion to open
repair.
DISCUSSION
Over 100 years ago, William Osler stated, “There is no
disease more conducive to clinical humility than aneurysm
of the aorta.” This statement has resonance for those
practitioners involved in the current management of
patients presenting with a diagnosis of rAAA. Recent large
population-based studies have shown a significant benefit
of endovascular repair over open repair for the elective
management of patients presenting with aneurysmal dis-
ease.3 In an analysis of over 60,000 patients in theMedicare
database between 2001 and 2004, endovascular repair was
associated with significantly lower adverse perioperative
outcomes to include death, medical, and surgical compli-
cations compared to open repair. In fact, a patient present-
ing with an aortic aneurysm was four times as likely to die,
es with increasing age (P  .008 in the pre-protocol eracreasseven times as likely to undergo a tracheostomy, and 12
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obstruction with an open repair as compared to EVAR.3
Aortic aneurysms are repaired to prevent death due to
rupture. The overall mortality of rAAAs is 85% (95% CI,
80%-91%) with nearly two-thirds of patients dying before
reaching a hospital.10 For those patients surviving to un-
dergo operation, the perioperative mortality rate is 41% to
48%.11,12 This mortality rate for open repair of rAAAs has
not changed significantly in over 2 decades.
EVAR for the repair of ruptured aneurysms (REVAR)
has recently been increasingly utilized and published mor-
tality rates with this approach vary between 24% and
46%.13-15 In a recent systematic review and meta-analysis,
Mastracci et al16 identified the pooled mortality after
REVAR to be 21% (95% CI, 13%-29%), but it was unclear
whether this was due to publication bias or benefit of the
technique. A significant finding in this review was that
algorithms or structured protocols served as surrogates for
an organized approach and could be an overall marker for
good quality care. In studies that utilized a structured
protocol, the mortality rate after REVARwas 18% (95%CI,
10%-26%), whereas in those studies without such proto-
cols, the mortality rate was 32% (95% CI, 20-44). The
current study strongly supports these findings. The imple-
mentation of a standardized protocol for the efficient eval-
uation and treatment of rAAAs is arguably at least as
important as the introduction of REVAR for improvement
in survival rates. Preparation is the hallmark of success to
any emergency protocol.
In a large American population-based study analyzing
28,123 admissions for rAAA between 2001 and 2004, the
utilization of REVAR increased from 6% to 11% with an
associated decline in mortality from 43% to 29% over the
same interval.17 Not surprisingly, the mortality rate from
open repair did not change, 40% to 43%. Patients undergo-
ing REVAR had lower mortality, shorter hospital stays, and
were more likely to be discharged to home. Another inter-
esting finding in this study was that mortality for REVAR
was significantly lower in teaching hospitals (21%) vs non-
teaching or community-based hospitals (55%).
There have been questions in the recent literature as to
the true value of REVAR, and it has been cited as a
“strategy in need of definitive evidence”.7 Hinchliffe et al7
reviewed 26 studies of REVAR vs open repair of rAAA
between 1994 and 2009. Of all of these studies reviewed,
not a single study demonstrated a significant difference in
30-day mortality between REVAR and open repair. The
largest study reviewed, however, encompassed 56 patients,
and the mortality varied across all studies between 0% and
53% for REVAR. The same review analyzed results from
several large population-based studies, which did in fact
demonstrate a significant benefit of REVAR over open
repair in all studies.17-21
A large review of our own experience with open repair
of rAAA published by Johansen et al2 in 1991, demon-
strated a mortality rate that exceeded that of the national
standard over the same time frame. Over a 10-year period
ending in 1989, 186 patients with rAAA were managed atHarborview Medical Center. Ninety percent of patients
had a pre-hospital SBP of 90 mm Hg on presentation.
Factors associated with a 90% likelihood of death were
age 80, female gender, hematocrit 25%, or transfusion
requirement 15 units. No patient undergoing CPR sur-
vived24 hours. The high mortality rate was attributed to
the unique pre-hospital system in Seattle that brings pa-
tients to care faster than in other large urban centers, where
similar patients would not survive longer transport times.
The results of our study are quite compelling in support
of the use of structured algorithms for the management of
patients presenting with rAAA. When comparing our own
single-institution experience in the contemporary era, we
reduced overall mortality from 57.8% to 35.3%. Unlike
other studies, hypotension or hemodynamic instability on
presentation was not used as a discriminator for candidacy
for REVAR or open repair. Much like contemporary large
population-based studies, our mortality from open repair
did not change significantly between the two time peri-
ods (57.8%-54.2%). However, mortality associated with
REVAR was an impressive 18.5%. We demonstrated an
absolute risk reduction of 22.5% (95% CI, 6.8%-38.2%)
with a relative risk reduction of 35% (95% CI, 14%-51%)
and an OR of 0.40 (95% CI, 0.20-0.78). The association
was still highly significant and clinically important after
adjustment for key factors predicting mortality (adjusted
OR  0.25; 95% CI, 0.10-0.57). The Kaplan-Meier anal-
ysis for late survival is meaningful only in that there was no
convergence of the survival curves in EVAR and open-
treated patients. Therefore, once patient’s survived the
perioperative period, they behaved similarly, regardless of
treatment. In the post-protocol period, as our experience
increased, there was a trend for increased utilization of
EVAR to treat rAAA from 46.3% of patients in year 1 to
63.2% in year 2 (P .20). One might expect the mortality
rate for open repair to actually rise in this setting due to the
increased complexity of repairing ruptured para- and juxta-
renal aneurysms or those with significant iliac calcification
who were not candidates for EVAR. Our mortality rate for
open repair did not change in the post-protocol period
suggesting a positive effect of a structured algorithm on the
open management of rAAAs.
In both the pre- and post-protocol periods of this
study, mortality increased with increasing age. When we
separated morality by EVAR vs open in the post-protocol
era, we found that mortality was lower with EVAR for all
age groups. A lower percentage of women underwent
EVAR in this study, and those that did tended to have
higher mortality rates, although the numbers were too
small to rule out this being due to chance.
Never having SBP 80 mm Hg in the pre-hospital
period was associated with 100% survival rate in themodern
post-protocol era. This was true for both open treatment
and EVAR groups. It seems intuitive that a more hemody-
namically stable patient with a ruptured aneurysm would
have a better overall outcome, and our results support this,
although the 100% survival rate is based on only 19 pa-
tients. Overall, transfusion requirement was associated with
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correlation between transfusion requirement andmortality.
Part of what is at play is that the transfusion is lower in the
post-protocol than in the pre-protocol, and in the post-
protocol group, it is lower for EVAR than for open repair.
When we looked at rupture times, there was evidence that
longer rupture times were associated with better survival.
This may be because those patients who are able to survive
long rupture and transport times are inherently more stable
than those who die en route. This statement, of course, is
purely speculative.
Important specific considerations for implementing a
structured algorithm for managing patients with rAAA can
be divided into those involving the pre-hospital system and
the index hospital admission. Pre-hospital consider-
ations involve effective communication between pre-
hospital personnel and the institution. Early notification is
clearly paramount. Furthermore, education of pre-hospital
personnel on the use of permissive hypotension, warming,
and avoidance of intubation to avoid exacerbation of he-
modynamic instability have become routine in ourmanage-
ment of these patients.
Hospital considerations involve efficiency with the per-
formance of REVAR. Those performing the procedure
should be highly experienced and capable of performing
EVAR in an expedient fashion in an area with equipment
and personnel who can rapidly convert to an open repair if
needed. At Harborview Medical Center, we are privileged
to have a “rupture room” that is prepared and maintained
after normal business hours and on weekends specifically
for the endovascular management of ruptured aneurysms.
Robust inventory is yet another hospital-specific consider-
ation for implementing a REVAR program. The ability to
place the appropriately sized components in any patient
represents efficient use of resources and is best overall for
the patient.
Changing routines and cultures within hospitals can be
challenging. Required is a physician champion who is pas-
sionate about the disease process and willing to train other
providers and staff to handle these emergencies. We have
convinced our anesthesiologists to keep patients awake
through the early phases of this process and believe that this
has significantly affected mortality. The best overall anes-
thetic management strategy has yet to be elucidated but
represents an area for future research. Also critically impor-
tant are the circulating and scrub nurses. Streamlining
instrument sets and simplifying processes help facilitate
rapid and seamless care.
Limitations of this study include the relative small size
of patients in the post-protocol period and the retrospective
nature of the data collection on the historic control group.
In addition, at the beginning of this study, a majority of
vascular surgeons in our practice did not possess the endo-
vascular skills required to independently perform EVAR.
This led to a bias for open repair in a small number of
patients early in the series. We anticipate that our mortality
rates for both REVAR and open repair will actually decline
even further as time goes on.CONCLUSIONS
Endovascular repair of rAAAs saves lives. Implementation
of a treatment algorithm with a preference for endovascular
repair of rAAAs is associated with a highly significant reduc-
tion in 30-daymortality. Successful implementationof a struc-
tured protocol relies on a dedicated experienced team of
physicians, nurses, and support staff, coordination of pre-
hospital/preoperative care, ready availability of equipment for
either open or endovascular repair, and robust in-house stent
graft inventory. Hospitals caring for patients with rAAAs
should have structured protocols in place and offer endovas-
cular repair. In a single urban hospital utilizing modern tech-
niques of resuscitation and surgicalmanagement, amajority of
patients presenting with an rAAA can survive.
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Dr Mark F. Fillinger (Lebanon, NH). Excellent talk, includ-
ing the emphasis on permissive hypotension. You also mentioned
the 12-French sheath. In our experience, the 12-French sheath
may be a little too flexible, if you do have to convert to open,
making it easier to dislodge. Once you open the aorta and you
decompress the aneurysm, I found that a 16- or 18-French sheath
is stiff enough to hold the balloon in place in the suprarenal aorta
without a person physically holding it or specifically focusing on it.
I was wondering if you could comment on that.
The second thing I’d like for you to comment on is that you
need to have a range of devices on inventory. We repaired two-
thirds of our ruptured aneurysms with endografts also. What do we
need to do to repair an even higher percentage, aside from devices
that will treat more severe anatomy?What were the criteria that you
used to perform open repair instead of endovascular?
Dr Starnes.Thank you for your questions. As far as the sheath
question goes, we have not seen that problem when opening
patients with a 12-French sheath in place. Typically we use a
Lunderquist wire in addition to a Coda balloon and a long 12-
French sheath that’s 45 cm in length. We usually have an intern or
a medical student hold the balloon catheter and sheath in place if it
needs to be inflated. The majority of the time the only reason that
the balloon needs to be inflated is during induction, that’s when
the patient is most likely to bottom out with an open repair. The
nice thing is that you can usually palpate the balloon when it’s
inflated and you really can get down safely and get control of the
aorta.
As far as your question on our inventory, we’re very fortunate
at Harborview to have a very large inventory of endovascular
supplies. We have over 250 stent-graft components, so we can put
the right graft into the right patient at the right time. And so
inventory is key. I’m not sure that having a rupture graft is going to
be something that’s going to be worthwhile in the future, at least
not now.
As far as what to do to get more patients sent to a regional
center, what we were able to do is to get into the culture of the
pre-hospital personnel, the medics. We went out and gave lectures
to medics. We convinced them that when they thought that a
patient had a known aneurysm that was ruptured, or were bringing
a patient to us, not to intubate them, to allow them to have relative
hypotension, and not to over resuscitate them. This is the time
period when we get into this game of coagulopathy and a spiral
toward death.
The other factor is to just increase the awareness in your owntalk this up and try and really market yourself as being the place for
all acute aortic emergencies.
Dr Fillinger. I assume you have your own vascular team on
call as well?
Dr Starnes. We don’t have any particular team on call. We
actually went into the hospital and trained the operating room staff
on weekends, and after normal business hours and we made the
endovascular sets as simple as we could. We didn’t teach them
about an Amplatz super stiff wire or a glidewire. We taught them
“blue wire”, “black wire” or “green wire”. We color coded every-
thing to make it very simple. And if it’s any more complicated than
that, usually the fellow or additional faculty will pick up on that and
be able to run with the procedure.
Dr Hasan H. Dosluoglu (Buffalo, NY ). I noticed that you
have about 10 hours-or-plus transport time and yet only half of
your patients, if I could see correctly, had a CAT scan. So I’m kind
of guessing it’s because they’re just wasting all the time flying in. Is
that why? Becausemost of the papers on this topic reported amuch
higher rate of obtaining a preoperative CAT scan.
Dr Starnes. Perhaps that figure didn’t come off very well. But
40% of our patients have transport times that are prolonged. For
the CT scans, only 66% of the patients in the pre-protocol open
group had CT scans. But in the post-protocol group, over 90% of
our patients had CT scans. And the majority of those patients had
CT scans to confirm the diagnosis already performed at that
outside hospital.
Dr Kaj Johansen (Seattle, Wash). Nineteen years ago before
this organization, I presented Part 1 of the Harborview experience
with ruptured abdominal aortic aneurysm, reporting in that series
a 70% mortality. I pointed out at that time that mortality hadn’t
really changed over the 45 years that graft repair for ruptured aortic
aneurysm had been available. Thus we really have heard new and
valuable information here today.
I reviewed my own responses to questions at my 1990 presen-
tation and must tell the tale on myself that I considered it unlikely
that any new technology would be found to be valuable in the
management of ruptured aortic aneurysm - this being a plea for
wider aneurysm screening. Obviously that was a profoundly erro-
neous observation just at the beginning of the endovascular era!
Your current paper does reiterate, however, two other issues
which I consider crucial: One, the value of a skilled and experi-
enced prehospital resuscitation and transport system; and two, the
morbid consequences of uncontrolled hypotension at any time in
these patients.
So I have a question for you in this regard. This is a very
specialized sort of team that you have developed at Harborview.
JOURNAL OF VASCULAR SURGERY
January 201018 Starnes et alHow can we generalize your experience and that of Dr. Mehta in
Albany to the rest of the country and particularly to suburban and
rural America where the majority of ruptured aneurysms continue
to occur?
Dr Starnes. I think that we absolutely must offer this
capability to all patients presenting with ruptured abdominalcommunity hospitals and in rural settings, whether this means
regionalization of care or satellite facilities, I don’t know but we
need to realize that a lot of these patients do survive a number of
hours. This may involve a re-evaluation of our pre-hospital
system for those of us who live in areas like Washington State,
but that is a vexing question and I’m not sure that I have a goodaortic aneurysms. However, we must figure this out in the answer for you.
